Ads
related to: jcr pharmaceuticals co ltd- Small Molecules Services
From API to Drug Product
Niche & Complex Small Molecules
- Services
Check the CDMO Services We Provide.
Request For More Information.
- Contact Us
Send Us Your Request
Our Experts Will Contact You
- Biologics Services
From Drug Substance to Drug Product
Upstream & Downstream Processing
- Small Molecules Services
abzena.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
In February 2016, Mesoblast's Licensee (JCR Pharmaceuticals Co., Ltd.) sold its first allogeneic cell product for the treatment of acute graft versus host disease (aGVHD) in children and adults in Japan. TEMCELL is the first allogeneic cell therapy to be fully approved in Japan. [10]
Founded in 1970, Jiangsu Hengrui Pharmaceuticals was originally state-owned and called Lianyungang Pharmaceutical Factory (Chinese: 连云港制药厂). [4][5] Headquartered in Lianyungang, Jiangsu, it was established in its current form in 1977. The company was listed on the Shanghai Stock Exchange in 2000 [6] and now has locations in China ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
Japan Credit Rating Agency. The Japan Credit Rating Agency (JCR), established in 1985, is a Japanese financial services company which publishes credit ratings to Japanese companies, local governments, and other interested parties. It provides ratings for 70% of financial companies and 60% of companies in other industries in Japan. [1]
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. [1] One subsidiary, China Pharmaceutical Group Co., Ltd (China Pharma) is based in Hong Kong.
It's not hard to see why Unilife is still unprofitable -- its measly $2.7 million in 2013 revenue was burned straight through by its high long-term debt, rising expenses, negative cash flow, and ...
Journal Citation Reports (JCR) is an annual publication by Clarivate. [1] It has been integrated with the Web of Science and is accessed from the Web of Science Core Collection. It provides information about academic journals in the natural and social sciences, including impact factors. JCR was originally published as a part of the Science ...
Ads
related to: jcr pharmaceuticals co ltdabzena.com has been visited by 10K+ users in the past month